Source: International Congress 2017 – Pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Otero Candelera (Sevilla, Spain). Study on microparticles in a posthrombotic hypertension animal model. 2365

Member's Comments

No comment yet.

Related content which might interest you: Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Characterization of a new rat model of heritable PAH Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Variation in mortality from pulmonary hypertension by aetiology Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 An epidemiological study of pulmonary arterial hypertension in Japan Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020 Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Reactive oxygen species production by rat neutrophils in pulmonary arterial hypertension experimental model Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013